ASMRDKXUBHLVBY-GNFLTPEISA-N
C35H36F6N4O5 — CID 56968956
Data last refreshed: (MolForge compound catalog, from PubChem)
About ASMRDKXUBHLVBY-GNFLTPEISA-N
ASMRDKXUBHLVBY-GNFLTPEISA-N (PubChem CID 56968956) has the molecular formula C35H36F6N4O5 and a molecular weight of 706.68 g/mol. Its IUPAC name is methyl 4-[3-[2-(azetidin-1-yl)-4-[[(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl]methyl]pyrimidin-5-yl]-4-methoxyphenyl]cyclohexane-1-carboxylate.
Molecular Properties
| Compound Name | ASMRDKXUBHLVBY-GNFLTPEISA-N |
|---|---|
| PubChem CID | 56968956 |
| Molecular Formula | C35H36F6N4O5 |
| Molecular Weight | 706.68 g/mol |
| Exact Mass | 706.26 |
| IUPAC Name | methyl 4-[3-[2-(azetidin-1-yl)-4-[[(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl]methyl]pyrimidin-5-yl]-4-methoxyphenyl]cyclohexane-1-carboxylate |
| SMILES | COC(=O)C1CCC(c2ccc(OC)c(-c3cnc(N4CCC4)nc3CN3C(=O)O[C@H](c4cc(C(F)(F)F)cc(C(F)(F)F)c4)[C@@H]3C)c2)CC1 |
| InChI | InChI=1S/C35H36F6N4O5/c1-19-30(23-13-24(34(36,37)38)16-25(14-23)35(39,40)41)50-33(47)45(19)18-28-27(17-42-32(43-28)44-11-4-12-44)26-15-22(9-10-29(26)48-2)20-5-7-21(8-6-20)31(46)49-3/h9-10,13-17,19-21,30H,4-8,11-12,18H2,1-3H3/t19-,20?,21?,30-/m0/s1 |
| InChIKey | ASMRDKXUBHLVBY-DPJJUJHNSA-N |
| XLogP | 7.93 |
| TPSA | 94.09 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 706.68 |
| LogP ≤ 5 | 7.93 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 56968956 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.